Glen Santangelo analyst JEFFERIES

Currently out of the existing stock ratings of Glen Santangelo, 76 are a BUY (61.79%), 44 are a HOLD (35.77%), 3 are a SELL (2.44%).

Glen Santangelo

Work Performance Price Targets & Ratings Chart

Analyst Glen Santangelo works at JEFFERIES with a stock forecast success ratio of 59.19% fulfilled within 158.46 days on average.

Glen Santangelo’s has documented 257 price targets and ratings displayed on 37 stocks. The coverage is on Healthcare, Consumer Defensive, Technology sectors.

Most recent stock forecast was given on TEVA, Teva Pharma Industries Ltd ADR at 23-Jan-2024.

Wall Street Analyst Glen Santangelo

Analyst best performing recommendations are on ALGN (ALIGN TECHNOLOGY).
The best stock recommendation documented was for ALGN (ALIGN TECHNOLOGY) at 10/7/2019. The price target of $200 was fulfilled within 4 days with a profit of $15.49 (8.4%) receiving and performance score of 20.99.

Average potential price target upside

ABC AmerisourceBergen BBLN Babylon Holdings Ltd CAH Cardinal Health DOCS Doximity DPLO Diplomat Pharmacy HCAT Health Catalyst HMSY HMS Holdings Corp HQY HealthEquity HSIC Henry Schein MCK McKesson MDSO Medidata Solutions PDCO Patterson Companies PGNY Progyny PHR Phreesia RAD Rite Aid TDOC Teladoc TRHC Tabula Rasa HealthCare WBA Walgreens Boots Alliance XRAY Dentsply Sirona ALGN Align Technology CVS CVS Health Corp GDRX Goodrx Holdings  RCM R1 RCM ACCD Accolade  AMWL American Well Corp ATHN athenahealth CHNG Change Healthcare HIMS Hims Hers Health DH Definitive Healthcare Corp TALK Talkspace VCRA Vocera Communications TEVA Teva Pharma Industries Ltd ADR VTRS Viatris SCPH Scpharmaceuticals AMPH Amphastar P VRCA Verrica Pharmaceuticals BHC Bausch Health Companies

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

215

$40.04 (22.89%)

187

8 months 6 days ago

14/15 (93.33%)

$28.91 (15.54%)

667

Hold

190

$15.04 (8.60%)

176

8 months 10 days ago

7/7 (100%)

$-0.86 (-0.45%)

477

Buy

220

$45.04 (25.74%)

213

8 months 10 days ago

11/17 (64.71%)

$29.14 (15.27%)

326

Buy

215

$40.04 (22.89%)

200

8 months 10 days ago

6/8 (75%)

$24.14 (12.65%)

220

Buy

225

$50.04 (28.60%)

184

8 months 12 days ago

11/12 (91.67%)

$36.39 (19.29%)

557

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Glen Santangelo is most bullish on?

Potential upside of $3 has been obtained for VRCA (VERRICA PHARMACEUTICALS)

Which stock is Glen Santangelo is most reserved on?

Potential downside of -$0.2 has been obtained for TEVA (TEVA PHARMA INDUSTRIES LTD ADR)

What Year was the first public recommendation made by Glen Santangelo?

On 2008

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?